Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current drug metabolism

• Publication date

  2017-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1389200218666170427112735PMID 28460623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.

  2016cited by this paper
• Urinary Vitamin D-Binding Protein as a Biomarker of Steroid-Resistant Nephrotic Syndrome

  2016cited by this paper
• Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer

  2016cited by this paper
• The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.

  2015cited by this paper
• Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial

  2014cited by this paper
• Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?

  2014cited by this paper
• Oral paricalcitol as antiproteinuric agent in chronic kidney disease.

  2013cited by this paper
• Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies

  2013cited by this paper
• Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression.

  2013cited by this paper
• Paricalcitol Reduces Proteinuria in Non‐Dialysis Chronic Kidney Disease Patients

  2013cited by this paper
• Anti‐Inflammatory Profile of Paricalcitol in Hemodialysis Patients: A Prospective, Open‐Label, Pilot Study

  2013cited by this paper
• Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis

  2012cited by this paper
• Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

  2012cited by this paper
• Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.

  2012cited by this paper
• Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

  2012cited by this paper
• Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study

  2012cited by this paper
• Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.

  2011cited by this paper
• The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?

  2011cited by this paper
• Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

  2010cited by this paper
• Vitamin D: Physiology and Pathophysiology

  2009cited by this paper
• Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

  2009cited by this paper
• Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.

  2009cited by this paper
• Pathophysiology of Calcium and Phosphate Metabolism Impairment in Chronic Kidney Disease

  2009cited by this paper
• Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation.

  2008cited by this paper
• Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

  2008cited by this paper
• Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs

  2008cited by this paper
• Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.

  2008cited by this paper
• Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease: A Randomized Double-Blind Pilot Trial

  2008cited by this paper
• Vitamin D and bone mineral density

  2007cited by this paper
• The case against ergocalciferol (vitamin D2) as a vitamin supplement.

  2006cited by this paper
• Antiproteinuric effect of oral paricalcitol in chronic kidney disease.

  2005cited by this paper
• Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States.

  2005cited by this paper
• 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.

  2005cited by this paper
• Pathogenesis of parathyroid hyperplasia in renal failure.

  2005cited by this paper
• Pathogenesis of vascular calcification in chronic kidney disease.

  2005cited by this paper
• The mechanism of calcium deposition in soft tissues.

  2005cited by this paper
• The pleiotropic actions of vitamin D.

  2004cited by this paper
• Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults.

  2004cited by this paper
• 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.

  2004cited by this paper
• In Situ Detection of 1,25-dihydroxyvitamin D Receptor In human Skeletal Muscle Tissue

  2004cited by this paper
• Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.

  2003cited by this paper
• Vitamin D and autoimmune diabetes

  2003cited by this paper
• Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

  2003cited by this paper
• Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function.

  2003cited by this paper
• The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells

  2003cited by this paper
• Aortic pulse wave velocity index and mortality in end-stage renal disease.

  2003cited by this paper
• The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.

  2002cited by this paper
• Pathophysiology and Recent Advances in the Management of Renal Osteodystrophy

  2002cited by this paper
• Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

  2002cited by this paper
• Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure.

  2002cited by this paper
• 1,25-Dihydroxyvitamin D Down-regulates Cell Membrane Growth- and Nuclear Growth-promoting Signals by the Epidermal Growth Factor Receptor*

  2002cited by this paper
• Ontogenesis of the vitamin D receptor in rat heart

  2002cited by this paper
• Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.

  2002cited by this paper
• Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

  2001cited by this paper
• Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.

  2001cited by this paper
• Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure.

  2001cited by this paper
• 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease.

  2000cited by this paper
• Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

  2000cited by this paper
• The role of osteoprogenitors in vascular calcification.

  2000cited by this paper
• Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

  2000cited by this paper
• Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.

  1999cited by this paper
• Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.

  1999cited by this paper
• Vitamin D receptor ontogenesis in rat liver

  1999cited by this paper
• Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord.

  1999cited by this paper
• Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.

  1999cited by this paper
• Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?

  1999cited by this paper
• Prolongation of allograft survival by 1,25-dihydroxyvitamin D3.

  1998cited by this paper
• Current understanding of the molecular actions of vitamin D.

  1998cited by this paper
• Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice.

  1998cited by this paper
• Secondary Hyperparathyroidism in the Elderly: Means to Defining Hypovitaminosis D

  1998cited by this paper
• 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis.

  1998cited by this paper
• Prevalence of Subclinical Vitamin D Deficiency in Different European Countries

  1998cited by this paper
• Hypovitaminosis D in medical inpatients.

  1998cited by this paper
• The hyperparathyroidism of chronic renal failure: a disorder of growth.

  1997cited by this paper
• How important is vitamin D deficiency in uraemia?

  1997cited by this paper
• Active serum vitamin D levels are inversely correlated with coronary calcification.

  1997cited by this paper
• Regulation of parathyroid cell proliferation

  1997cited by this paper
• A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism.

  1996cited by this paper
• Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure.

  1996cited by this paper
• 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.

  1996cited by this paper
• Serum vitamin D concentrations among elderly people in Europe.

  1995cited by this paper
• Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

  1995cited by this paper
• A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

  1995cited by this paper
• Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients.

  1994cited by this paper
• Vitamin D deficiency suppresses cell-mediated immunity in vivo.

  1993cited by this paper
• 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice.

  1992cited by this paper
• Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.

  1991cited by this paper
• Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat.

  1991cited by this paper
• Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers.

  1991cited by this paper
• Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat.

  1990cited by this paper
• Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells.

  1989cited by this paper
• Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer.

  1989cited by this paper
• 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia.

  1989cited by this paper
• The influence of hyperparathyroidism on glucose metabolism in uremia.

  1985cited by this paper
• Defective photoproduction of cholecalciferol in normal and uremic humans.

  1984cited by this paper
• Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients.

  1981cited by this paper
• Biochemical evidence for 1,25-dihydroxyvitamin D receptor macromolecules in parathyroid, pancreatic, pituitary, and placental tissues.

  1980cited by this paper
• Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.

  1980cited by this paper
• Central nervous system manifestations of hyperparathyroidism.

  1978cited by this paper
• Vitamin-D deficiency in the osteomalacia of chronic renal failure.

  1976cited by this paper

• Relationship between Secondary Hyperparathyroidism and Hypertension in Chronic Kidney Disease

  2025cites this paper
• THE EFFECT OF THE VITAMIN D LEVEL ON THE CLINICAL, LABORATORY, AND OUTCOME IN PATIENTS OVER 65 YEARS OF AGE WITH COVID-19: COMPREHENSIVE TERTIARY CENTER EXPERIENCE

  2021cites this paper
• Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD)

  2019influential citation
• Decreased 25-Hydroxyvitamin D Level Is Linked to Anemia in Peritoneal Dialysis Patients

  2019influential citation
• New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology

  2019cites this paper
• Role of Vitamin D Status in Diabetic Patients with Renal Disease

  2019cites this paper
• Mini review A reevaluation of nutritional vitamin D in the treatment of chronic kidney disease

  year unknowncites this paper